A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Original Source:
https://www.foxnews.com/health/new-pancreatic-cancer-pill-could-reshape-treatment-early-trial-results-stun-researchers
